ArticlePublished Jul 2, 2026 · Reviewed Sep 28, 2026

What Is an Aberrant NDC?

Short answer

An aberrant NDC is a product, identified by its National Drug Code, that appears on a defined aberrant-product list networks use when they look at a pharmacy's dispensing mix. It is about billing patterns and network review, not a clinical judgment about the product itself.

Why NDCs, not drug names

A single drug can have many NDCs across manufacturers, strengths, and package sizes. Using the NDC makes the list precise: a specific packaged product is on the list, not a whole drug class.

How matching works

  • NDCs are compared in canonical 11-digit form.
  • A 10-digit NDC is padded to 11 based on its segment layout (for example 4-4-2, 5-3-2, or 5-4-1).
  • Unhyphenated codes are checked against common variants, so a match is found either way.

10-digit layouts and their 11-digit forms

10-digit layoutWhere the zero is addedExample
4-4-2Front of the labeler segment0310-0737-30 → 00310-0737-30
5-3-2Front of the product segment50242-051-27 → 50242-0051-27
5-4-1Front of the package segment60505-2632-6 → 60505-2632-06
No hyphensAll three variants are triedA match on any variant counts

How the list stays current

CVS Caremark publishes additions to its aberrant product list through Network Contract Education notices, and each notice carries an effective date. The September 24, 2026 notice added 40 products effective November 1, 2026, following 34 additions effective August 1 and 46 effective September 1. PharmaFix bundles each dated addition and applies it only to claims filled on or after its effective date, so an October report is not checked against products that join the list in November. The same notices restate the Caremark-managed BIN list and the Healthfirst RXGRP values; both are checked against the bundled reference on every update.

Scope and limitations

This article is general product information, not legal, clinical, contracting, audit, or dispensing advice. PharmaFix uses the supported fields and bundled reference data described in the product; it does not speak for any payer or guarantee that a payer will calculate or act the same way. Review current network documents and obtain professional advice where appropriate.

Common mistakes

  • Assuming an aberrant NDC is a clinical red flag; the list is about billing mix, not appropriateness.
  • Matching only exact 11-digit strings and missing 10-digit or unhyphenated codes.
  • Using a stale list; results are only as current as the aberrant-NDC list you check against.

How PharmaFix helps

PharmaFix normalizes supported NDC formats, compares candidate values with the analyzer's bundled reference set, and estimates how much of the report's paid dollars and claim count are tied to matched products. It helps you review the report; it does not judge a product or make dispensing recommendations.

Frequently asked questions

Does an aberrant NDC mean I did something wrong?

No. The list reflects billing patterns networks watch, not a clinical or legal judgment. PharmaFix simply helps you see how much of your mix those products represent.

How current is the list?

Last reviewed September 28, 2026. The analyzer applies 34 additions on or after August 1, 2026, 46 more on or after September 1, and 40 more on or after November 1, so an August report is checked against 1,736 effective NDCs, a September or October report against 1,782, and a November report against 1,822. Other entries remain dependent on the bundled source history; confirm current payer documents.

Estimate your report's position against the 25% reference line

Upload only an authorized PrimeRx or Caremark report without direct patient identifiers. PharmaFix calculates report-based rates and is designed not to retain report rows or results.

Related reading